Peripheral Stent Study Design Panel, Endpoint Data Development Urged
This article was originally published in The Gray Sheet
Executive Summary
FDA should establish a cross-disciplinary committee to aid manufacturers designing clinical trials supporting PMAs for iliac artery stenting and other peripheral indications, vascular interventionalists advised the agency's Circulatory System Devices Panel at an April 23 meeting in Silver Spring, Maryland.